🐬
|
Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
A. Rosenberg,
P. Friedmann,
Jaydira Del Rivero,
S. Libutti,
A. Laird
|
6 |
2016 |
6 🐬
|
🐜
|
Anti–PD-L1 Treatment Induced Central Diabetes Insipidus
8 auth.
Chen Zhao,
S. Tella,
Jaydira Del Rivero,
Anuhya Kommalapati,
Ifechukwude Ebenuwa,
J. Gulley,
...
J. Strauss,
I. Brownell
|
6 |
2017 |
6 🐜
|
🐜
|
Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis‐Hyperphosphatemia Syndrome
20 auth.
M. Ramnitz,
P. Gourh,
R. Goldbach-Mansky,
F. Wodajo,
S. Ichikawa,
Michael J. Econs,
K. White,
A. Molinolo,
Marcus Y. Chen,
T. Heller,
...
Jaydira Del Rivero,
Patricia W. Seo-Mayer,
B. Arabshahi,
Malaka B. Jackson,
Sarah Hatab,
E. McCarthy,
L. Guthrie,
B. Brillante,
R. Gafni,
Michael T. Collins
|
6 |
2016 |
6 🐜
|
🐜
|
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma
18 auth.
L. Fishbein,
Jaydira Del Rivero,
T. Else,
J. Howe,
S. Asa,
D. Cohen,
P. Dahia,
D. Fraker,
K. Goodman,
T. Hope,
...
P. Kunz,
K. Perez,
N. Perrier,
D. Pryma,
Mabel Ryder,
A. Sasson,
M. Soulen,
C. Jimenez
|
6 |
2021 |
6 🐜
|
🐜
|
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
22 auth.
Meghali Goswami,
Gege Gui,
L. Dillon,
K. Lindblad,
Julie Thompson,
Janet Valdez,
Dong-Yun Kim,
J. Ghannam,
K. Oetjen,
C. DeStefano,
...
Dana M Smith,
H. Tekleab,
Yeusheng Li,
Pradeep K. Dagur,
Thomas E. Hughes,
J. Marté,
Jaydira Del Rivero,
Joanna Klubo-Gwiezdzinksa,
J. Gulley,
K. Calvo,
Catherine Lai,
C. Hourigan
|
5 |
2021 |
5 🐜
|
🐜
|
Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.
28 auth.
R. Därr,
J. Nambuba,
Jaydira Del Rivero,
Ingo Janssen,
M. Merino,
M. Todorović,
B. Balint,
I. Jochmanova,
Josef T Prchal,
Ronald M Lechan,
A. Tischler,
V. Popović,
D. Miljić,
K. Adams,
F. Prall,
...
A. Ling,
M. Golomb,
Michael J Ferguson,
N. Nilubol,
Clara C Chen,
E. Chew,
D. Taïeb,
C. Stratakis,
T. Fojo,
Chunzhang Yang,
E. Kebebew,
Z. Zhuang,
K. Pacak
|
5 |
2016 |
5 🐜
|
🦁
|
Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management.
Jaydira Del Rivero,
L. Cordes,
J. Klubo-Gwiezdzinska,
R. Madan,
L. Nieman,
J. Gulley
|
5 |
2019 |
5 🦁
|
🐜
|
The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study
11 auth.
J. Schovanek,
Victoria L. Martucci,
R. Wesley,
T. Fojo,
Jaydira Del Rivero,
Thanh T. Huynh,
...
K. Adams,
E. Kebebew,
Z. Fryšák,
C. Stratakis,
K. Pacak
|
5 |
2014 |
5 🐜
|
🐢
|
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
Maran Ilanchezhian,
Abhishek Jha,
K. Pacak,
Jaydira Del Rivero
|
5 |
2020 |
5 🐢
|